​

Prestige Consumer Healthcare (PBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PBH Stock Forecast

Prestige Consumer Healthcare (PBH) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $71.00, with a high of $71.00 and a low of $71.00. This represents a 14.46% increase from the last price of $62.03.

$60 $65 $70 $75 $80 $85 High: $71 Avg: $71 Low: $71 Last Closed Price: $62.03

PBH Stock Rating

Prestige Consumer Healthcare stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (70.59%), 3 Hold (17.65%), 2 Sell (11.76%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 2 3 12 Strong Sell Sell Hold Buy Strong Buy

PBH Price Target Upside V Benchmarks

TypeNameUpside
StockPrestige Consumer Healthcare14.46%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks9.06%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$71.00$71.00$78.50
Last Closing Price$62.03$62.03$62.03
Upside/Downside14.46%14.46%26.55%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25141--6
Sep, 25132--6
Aug, 25-34--7
Jul, 25-34--7
Jun, 25-33-17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 27, 2025Jefferies$71.00$61.9614.59%14.46%
Nov 05, 2024SUsan AndersonCanaccord Genuity$86.00$74.5815.31%38.64%
Jun 21, 2024Linda Bolton WeiserD.A. Davidson$93.00$68.1336.50%49.93%
Nov 17, 2022Canaccord Genuity$71.00$58.3521.68%14.46%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 21, 2025OppenheimerOutperformOutperformhold
Nov 05, 2024Canaccord GenuityBuyBuyhold
Sep 23, 2024JefferiesBuyHolddowngrade
Nov 17, 2022Canaccord GenuityBuyinitialise
May 10, 2022JefferiesBuyupgrade
May 09, 2022OppenheimerOutperformupgrade

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 $5 $6 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$3.28$4.09$-1.65$4.21---
Avg Forecast$3.23$4.03$4.18$4.33$4.44$4.78$5.05
High Forecast$3.26$4.07$4.22$4.37$4.49$4.82$5.18
Low Forecast$3.22$4.02$4.14$4.29$4.40$4.74$4.92
Surprise %1.55%1.49%-139.47%-2.77%---

Revenue Forecast

$900M $960M $1B $1B $1B $1B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$943.37M$1.09B$1.13B$1.13B---
Avg Forecast$936.15M$1.08B$1.12B$1.14B$1.13B$1.16B$1.18B
High Forecast$943.52M$1.09B$1.13B$1.14B$1.14B$1.17B$1.18B
Low Forecast$933.69M$1.08B$1.11B$1.13B$1.12B$1.15B$1.18B
Surprise %0.77%0.81%0.62%-0.92%---

Net Income Forecast

$-100M $-20M $60M $140M $220M $300M Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$164.68M$205.38M$-82.31M$209.34M---
Avg Forecast$146.38M$161.90M$209.81M$-80.67M$224.15M$239.71M$253.40M
High Forecast$175.66M$194.28M$211.97M$-64.54M$225.25M$241.73M$259.79M
Low Forecast$117.10M$129.52M$207.87M$-96.81M$220.76M$237.70M$247.01M
Surprise %12.50%26.86%-139.23%-359.50%---

PBH Forecast FAQ

Is Prestige Consumer Healthcare stock a buy?

Prestige Consumer Healthcare stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 3 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Prestige Consumer Healthcare is a favorable investment for most analysts.

What is Prestige Consumer Healthcare's price target?

Prestige Consumer Healthcare's price target, set by 17 Wall Street analysts, averages $71 over the next 12 months. The price target range spans from $71 at the low end to $71 at the high end, suggesting a potential 14.46% change from the previous closing price of $62.03.

How does Prestige Consumer Healthcare stock forecast compare to its benchmarks?

Prestige Consumer Healthcare's stock forecast shows a 14.46% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical distribution stocks industry (9.06%).

What is the breakdown of analyst ratings for Prestige Consumer Healthcare over the past three months?

  • October 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 16.67% Strong Buy, 50.00% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 42.86% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.

What is Prestige Consumer Healthcare’s EPS forecast?

Prestige Consumer Healthcare's average annual EPS forecast for its fiscal year ending in March 2025 is $4.44, marking a 5.46% increase from the reported $4.21 in 2024. Estimates for the following years are $4.78 in 2026, and $5.05 in 2027.

What is Prestige Consumer Healthcare’s revenue forecast?

Prestige Consumer Healthcare's average annual revenue forecast for its fiscal year ending in March 2025 is $1.13B, reflecting a 0.64% increase from the reported $1.13B in 2024. The forecast for 2026 is $1.16B, and $1.18B for 2027.

What is Prestige Consumer Healthcare’s net income forecast?

Prestige Consumer Healthcare's net income forecast for the fiscal year ending in March 2025 stands at $224.15M, representing an 7.07% increase from the reported $209.34M in 2024. Projections indicate $239.71M in 2026, and $253.4M in 2027.